CoreMap

CoreMap is a development-stage medical device company based in Burlington, Vermont. The company specializes in advanced diagnostic technology aimed at treating complex cardiac arrhythmias, particularly atrial fibrillation (AF). CoreMap's mission is to enhance patient outcomes by providing electrophysiologists with tools for patient-specific treatment options, recognizing the need for tailored approaches in managing AF, which affects around 33 million people globally. The company's core technology improves the visualization and mapping of atrial arrhythmias, enhancing spatial resolution and sample density. This allows physicians to accurately identify the sources and mechanisms of AF, supporting the creation of individualized treatment plans that focus on curing persistent and permanent AF rather than just managing symptoms. CoreMap has completed numerous pre-clinical studies and secured $10.5 million in Series A financing to further develop its technology. The leadership team includes experienced professionals from the medical technology field, dedicated to advancing care for patients with cardiac arrhythmias.

• Employees 38
• Founded 2016
• Annual Revenue $4000000
• Total Funding $40817466